Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment
Authors
Keywords
-
Journal
Transplant Infectious Disease
Volume 18, Issue 1, Pages 44-54
Publisher
Wiley
Online
2015-11-17
DOI
10.1111/tid.12485
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epstein–Barr virus lymphoproliferative disease after hematopoietic stem cell transplant
- (2014) Rayne H. Rouce et al. CURRENT OPINION IN HEMATOLOGY
- EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era
- (2013) C P Fox et al. BONE MARROW TRANSPLANTATION
- Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
- (2013) Jan Styczynski et al. CLINICAL INFECTIOUS DISEASES
- Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab
- (2013) F. Patriarca et al. Transplant Infectious Disease
- Incidence, kinetics, and risk factors of Epstein-Barr virus viremia in pediatric patients after allogeneic stem cell transplantation
- (2012) Victoria Bordon et al. PEDIATRIC TRANSPLANTATION
- In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT
- (2011) A Dominietto et al. BONE MARROW TRANSPLANTATION
- Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation
- (2011) S. Ruf et al. JOURNAL OF CLINICAL VIROLOGY
- Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation
- (2011) Z Peric et al. LEUKEMIA
- Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation
- (2010) Stefania Coppoletta et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation
- (2010) Ben Carpenter et al. TRANSPLANTATION
- Interlaboratory Comparison of Epstein-Barr Virus Viral Load Assays
- (2009) J. K. Preiksaitis et al. AMERICAN JOURNAL OF TRANSPLANTATION
- How I treat EBV lymphoproliferation
- (2009) H. E. Heslop BLOOD
- Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children
- (2009) M Faraci et al. BONE MARROW TRANSPLANTATION
- Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
- (2009) H. Omar et al. Transplant Infectious Disease
- Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation
- (2009) Imran Ahmad et al. TRANSPLANTATION
- Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
- (2008) J Styczynski et al. BONE MARROW TRANSPLANTATION
- Kinetics of Epstein-Barr Virus DNA Load in Different Blood Compartments of Pediatric Recipients of T-Cell-Depleted HLA-Haploidentical Stem Cell Transplantation
- (2008) F. Baldanti et al. JOURNAL OF CLINICAL MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started